Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Tax Payment
Common stock, $0.0001 par value
2020-03-01$2.93/sh−673$1,972→ 14,628 total
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.